Feb 28 (Reuters) - Grand Pharmaceutical Group Ltd 0512.HK:
UPDATE ON STRATEGIC INVESTMENT IN TELIX
DEAL FOR AU$143 MILLION.
DISPOSED 45.2% OF ITS HOLDIN IN TELIX PHARMACEUTICALS
INTENTION NOT TO SELL REMAINING TELIX SHARES WITHIN NEXT 12 MONTHS
Further company coverage: 0512.HK
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.